John Golden - Athene Holding Executive Vice President, General Counsel
President
Mr. John L. Golden is Executive Vice President Legal of the Company. Prior to joining Athene, John was an attorney at Sidley Austin LLP. At Sidley, John represented a variety of financial institutions in connection with all aspects of their businesses such as corporate transactions, securities offerings, regulatory and compliance, enforcement matters and employment matters. Prior to Sidley, John worked for Fisher Investments and IBM Corporationrationration. John received his Juris Doctor from the University of California, Los Angeles, where he was second in his class, and a BS in Operations ManagementInformation Systems from Santa Clara University. John is admitted to the State Bar of California. since 2018.
| Age | 40 |
| Tenure | 6 years |
| Phone | 441-279-8400 |
| Web | https://www.athene.com |
Athene Holding Management Efficiency
The company has Return on Asset of 1.36 % which means that on every $100 spent on assets, it made $1.36 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 20.13 %, implying that it generated $20.13 on every 100 dollars invested. Athene Holding's management efficiency ratios could be used to measure how well Athene Holding manages its routine affairs as well as how well it operates its assets and liabilities.Athene Holding has 2.47 B in debt with debt to equity (D/E) ratio of 0.11, which may show that the company is not taking advantage of profits from borrowing. Athene Holding has a current ratio of 4.01, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Athene to invest in growth at high rates of return.
Similar Executives
| Found 4 records | PRESIDENT Age | ||
| Christopher Fenimore | Regeneron Pharmaceuticals | 53 | |
| Joseph LaRosa | Regeneron Pharmaceuticals | 65 | |
| Daniel Plew | Regeneron Pharmaceuticals | 51 | |
| Marion McCourt | Regeneron Pharmaceuticals | 64 | |
Management Performance
| Return On Equity | 20.13 | |||
| Return On Asset | 1.36 |
Athene Holding Leadership Team
Elected by the shareholders, the Athene Holding's board of directors comprises two types of representatives: Athene Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Athene. The board's role is to monitor Athene Holding's management team and ensure that shareholders' interests are well served. Athene Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Athene Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gernot Lohr, Director | ||
| Randall Epright, Executive Vice President and Chief Information Officer, Athene Holding Ltd | ||
| Michael Downing, Executive Vice President and Chief Actuary | ||
| Manfred Puffer, Director | ||
| Marc Rowan, Director | ||
| Marc Beilinson, Lead Independent Director | ||
| William Wheeler, President | ||
| Mitra Hormozi, Independent Director | ||
| Kristi Burma, Executive Vice President - Human Resources | ||
| Lynn Swann, Independent Director | ||
| H McCall, Independent Director | ||
| Fehmi Zeko, Independent Director | ||
| Lawrence Ruisi, Independent Director | ||
| Martin Klein, Chief Financial Officer, Executive Vice President | ||
| James Belardi, Chairman of the Board, Chief Executive Officer, Chief Investment Officer | ||
| Brian Leach, Independent Director | ||
| Matthew Michelini, Director | ||
| Hope Taitz, Independent Director | ||
| Scott Kleinman, Director | ||
| Sarah VanBeck, Senior Vice President Principal Accounting Officer, Controller | ||
| Arthur Wrubel, Independent Director | ||
| Doug Niemann, Executive Vice President Chief Risk Officer | ||
| Robert Borden, Independent Director | ||
| Grant Kvalheim, Executive Vice President - Athene, Chief Executive Officer and President - Athene USA | ||
| John Golden, Executive Vice President, General Counsel |
Athene Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Athene Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 20.13 | |||
| Return On Asset | 1.36 | |||
| Profit Margin | 13.69 % | |||
| Operating Margin | 16.05 % | |||
| Current Valuation | 8.73 B | |||
| Shares Outstanding | 192.14 M | |||
| Shares Owned By Insiders | 2.98 % | |||
| Shares Owned By Institutions | 87.92 % | |||
| Number Of Shares Shorted | 5.02 M | |||
| Price To Earning | 4.42 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Athene Stock
If you are still planning to invest in Athene Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Athene Holding's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |